Skip to main content
. 2020 Oct 22;268(4):1330–1341. doi: 10.1007/s00415-020-10279-7

Table 2.

Means for time to EDSS 6 in five subgroups, patients diagnosed before or after 2006 and BT vs. Non-BT patients

Years to EDSS 6 95% CI Reached EDSS 6 % p value
BOT-1 29.8 28.4–31.1 34.5
BT-living 30.4 28.5–32.4 31.2
G1 (diagnosed ≤ 1997) 26.7 25.0–28.5 70.5  < 0.001
G2 (1998–2002) 25.9 23.5–28.3 48.5
G3 (2003–2007) 31.5 28.2–34.8 31.3
G4 (2008–2012) 36.0 31.6–40.4 12.7
G5 (2013–2017) 42.8 36.6–49.1 3.7
Patients diagnosed < 2006 27.6 26.2–29.0 57.8  < 0.001
Patients diagnosed ≥ 2006 35.3 32.0–38.6 12.3
BT patients 27.3 25.8–28.9 40.4  < 0.001
Non-BT patients 33.8 31.6–35.9 26.7
Relapsing at onset 32.2 30.7–33.7 27.1  < 0.001
Progressive at onset 13.9 12.1–15.7 70.3
Progressiv at onset
 G1 (diagnosed ≤ 1997) 12.0 9.6–14.4 96.8 0.04
 G2 (1998–2002) 10.8 8.5–13.1 87.9
 G3 (2003–2007) 11.1 8.6–13.6 74.3
 G4 (2008–2012) 19.5 14.0–25.0 46.3
 G5 (2013–2017) 17.2 11.0–17.0 29.6

BOT-1 database of all 2097 patients from Buskerud, Oslo and Telemark included in study, BT-living: geographically complete and living population from Buskerud and Telemark, BT Buskerud and Telemark, Non-BT everyone in BOT-1 who does not reside in Buskerud or Telemark, CI confidence interval